World's Best Scientists 2026 revealed!
Euphrosyne Gouzoulis-Mayfrank

Euphrosyne Gouzoulis-Mayfrank

D-Index & Metrics

Psychology

D-Index
45
Citations
6347
World Ranking
6776
National Ranking
322

Euphrosyne Gouzoulis-Mayfrank publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Euphrosyne Gouzoulis-Mayfrank sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 152 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Euphrosyne Gouzoulis-Mayfrank D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Euphrosyne Gouzoulis-Mayfrank sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 45 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Euphrosyne Gouzoulis-Mayfrank is affiliated with the University of Cologne in Germany and has contributed extensively to research in psychology and medicine. Their work primarily spans clinical psychology, general health professions, social psychology, psychiatry, and mental health, as well as applied psychology.

Their research topics focus on several key areas, including:

  • Psychiatric care and mental health services
  • Mental health treatment and access
  • Healthcare decision-making and restraints
  • Digital mental health interventions
  • Schizophrenia research and treatment
  • Migration, health, and trauma
  • Psychedelics and drug studies

Euphrosyne Gouzoulis-Mayfrank has published in frequent venues such as:

  • Psychiatrische Praxis
  • SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  • BMC Psychiatry
  • Der Nervenarzt
  • BMC Health Services Research

Among their recent papers are:

  • "Upscaling e-mental health in Europe: a six-country qualitative analysis and policy recommendations from the eMEN project" (2020), published in European Archives of Psychiatry and Clinical Neuroscience
  • "Utilization of Inpatient Mental Health Care in the Rhineland During the COVID-19 Pandemic" (2021), published in Frontiers in Public Health
  • "Identification of risk factors for involuntary psychiatric hospitalization: using environmental socioeconomic data and methods of machine learning to improve prediction" (2020), published in BMC Psychiatry
  • "From formative research to cultural adaptation of a face-to-face and internet-based cognitive-behavioural intervention for Arabic-speaking refugees in Germany" (2021), published in Clinical Psychology in Europe
  • "Adapting and Implementing Apps for Mental Healthcare" (2022), published in Current Psychiatry Reports

The scientist has collaborated frequently with co-authors including:

  • Jürgen Zielasek
  • Isabell Lehmann
  • Mario Schmitz-Buhl
  • Isabelle Reinhardt
  • Anil Batra

Best Publications

  • Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

    Euphrosyne Gouzoulis-Mayfrank;Jörg Daumann;Frank Tuchtenhagen;Susanne Pelz

  • Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.

    E. Gouzoulis-Mayfrank;K. Heekeren;A. Neukirch;M. Stoll

  • Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

    Euphrosyne Gouzoulis-Mayfrank;Mathias Schreckenberger;Mathias Schreckenberger;Osama Sabri;Christoph Arning

  • Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?

    E. Gouzoulis-Mayfrank;J. Daumann

  • The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

    Euphrosyne Gouzoulis-Mayfrank;Jörg Daumann

  • Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.

    Karsten Heekeren;Jörg Daumann;Anna Neukirch;Carsten Stock

  • Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

    E Gouzoulis-Mayfrank;B Thelen;E Habermeyer;H J Kunert

  • Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.

    Euphrosyne Gouzoulis-Mayfrank;Bastian Thimm;Markus Rezk;Gernot Hensen

  • Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia.

    Ulrich Meincke;Gregory A Light;Mark A Geyer;David L Braff

  • The impact of early-onset cannabis use on functional brain correlates of working memory

    Benjamin Becker;Daniel Wagner;Euphrosyne Gouzoulis-Mayfrank;Elmar Spuentrup

  • Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

    Jörg Daumann;Gernot Hensen;Bastian Thimm;Markus Rezk

  • Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines.

    Euphrosyne Gouzoulis-Mayfrank;Joerg Daumann

  • The role of cannabis in cognitive functioning of patients with schizophrenia.

    Thomas Schnell;Dagmar Koethe;Jörg Daumann;Euphrosyne Gouzoulis-Mayfrank

  • Increased activation of indirect semantic associations under psilocybin

    Manfred Spitzer;Markus Thimm;Leo Hermle;Petra Holzmann

  • High Intensity Dependence of Auditory Evoked Dipole Source Activity Indicates Decreased Serotonergic Activity in Abstinent Ecstasy (MDMA) Users

    Frank Tuchtenhagen;Jörg Daumann;Christina Norra;René Gobbelé

  • Quantitation of psilocin in human plasma by high-performance liquid chromatography and electrochemical detection: comparison of liquid-liquid extraction with automated on-line solid-phase extraction.

    Hiltrud Lindenblatt;Edda Krämer;Petra Holzmann-Erens;Euphrosyne Gouzoulis-Mayfrank

  • Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

    Joerg Daumann;Susanna Pelz;Stefanie Becker;Frank Tuchtenhagen

  • Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.

    E Gouzoulis-Mayfrank;K Heekeren;B Thelen;H Lindenblatt

  • Semantic hyperpriming in thought-disordered patients with schizophrenia: state or trait?--a longitudinal investigation.

    Euphrosyne Gouzoulis-Mayfrank;Tatjana Voss;Dina Mörth;Bernhard Thelen

  • Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: Evidence from an 18-month longitudinal functional magnetic resonance imaging study

    Jörg Daumann;Thomas Fischermann;Karsten Heekeren;Armin Thron

Frequent Co-Authors

Benjamin Becker
Benjamin Becker University of Hong Kong
Manfred Spitzer
Manfred Spitzer University of Ulm
Mark A. Geyer
Mark A. Geyer University of California, San Diego
Marc Tittgemeyer
Marc Tittgemeyer Max Planck Society
Martin Driessen
Martin Driessen Bielefeld University
Manfred Schedlowski
Manfred Schedlowski University of Duisburg-Essen
Christiane M. Thiel
Christiane M. Thiel Carl von Ossietzky University of Oldenburg
Eva M. Müller-Oehring
Eva M. Müller-Oehring Stanford University
Helmut Buchner
Helmut Buchner RWTH Aachen University
Frank Schneider
Frank Schneider Heinrich Heine University Düsseldorf

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing an online psychology degree in the USA opens doors to a variety of rewarding career paths. One popular option is becoming a Board Certified Behavior Analyst (BCBA), a credential that is in high demand across educational, clinical, and community settings.

Each state may have different requirements, so it’s crucial to understand the specific pathway based on where you plan to practice. For example, if you’re interested in how to become a bcba in Louisville, knowing the local regulations and necessary coursework is essential for success. Similarly, understanding the bcba certification requirements in Lubbock will help you plan your degree or training.

Those looking to practice elsewhere can explore the bcba certification requirements in Madison or review Memphis bcba education requirements. These resources provide detailed guidance on educational prerequisites, supervised experience, and exam preparation.

Earning an online degree in psychology or a related field is often the first step. From there, specialized certifications like BCBA can significantly expand your career opportunities in psychology, behavioral therapy, and mental health services.

Best Scientists Citing Euphrosyne Gouzoulis-Mayfrank

Trending Scientists